Connect with us

News

SpaceX snags launch contract from Arianespace after Vega rocket fails twice

(Richard Angle)

Published

on

In a rare victory for international launch competition, SpaceX has snagged a contract to launch an Italian Earth observation satellite from European launch monopoly and political heavyweight Arianespace.

After spending the better part of a decade treading water as SpaceX’s Falcon 9 rocket came to dominate the global launch market, Arianespace has become increasingly reliant on European Space Agency (ESA) and European Union (EU) agreements that require signatories to launch domestic satellites and spacecraft on the Ariane 5, Ariane 6, and Italian Vega rockets. Save for a few slow-moving technology development programs that have yet to bear any actionable fruit, the company – heavily subsidized by the European Union – has almost completely failed to face the threat posed by SpaceX head-on by prioritizing the development of rockets that can actually compete with Falcon 9 and Falcon Heavy on cost, performance, and availability.

Instead, over the last five or so years, Arianespace and the European Space Agency have increasingly pursued political agreements and legislation that commit member states to only fly payloads on Ariane 5, Ariane 6, and Vega rockets if at all possible.

A recent development offers the best look yet at what many European space agencies likely suffer through as a consequence of their governments signing away access to an increasingly competitive launch industry – often seemingly in return for Arianespace selecting contractors or (re)locating development hubs or factories in certain countries. Notably, sometime in September 2021, the Italian Space Agency (ASI) confirmed signs that it was moving the launch of its COSMO SkyMed CSG-2 Earth observation satellite from a new Arianespace rocket to SpaceX’s Falcon 9.

The second COSMO SkyMed Second Generation satellite (CSG-2) was planned to be launched with VEGA-C within 2021, but the launcher development has been impacted by the VV15 and VV17 failures and, above all, by the COVID pandemic. The delays, postponing the VEGA-C Maiden Flight to Q1 2022, with a consequent tight schedule of launches in 2022, made the launch period of CSG-2 no longer compatible with the needs of the COSMO Mission. Since Arianespace backlog was already full on Soyuz and Ariane systems in 2021, it was not possible to have a European backup solution compliant with the CSG-2 schedule, thus an alternative solution with the US provider SPACE X has been adopted allowing to keep the CSG-2 launch within the current year. In line with its long-lasting support ensured to the European launch industry, ASI confirmed its trust in Arianespace and VEGA-C capabilities by contracting the launch of the CSG-3 satellite, planned for 2024. Moreover, other future launch opportunities for ASI missions with VEGA-C are under discussion, confirming Arianespace as a key partner for the Agency.

Italian Space Agency (ASI) – September 2021

Advertisement

Weighing around 2.2 tons (~4900 lb), SkyMed CSG-2 is the second of four synthetic aperture radar (SAR) satellites designed to “[observe] Earth from space, meter by meter, day and night, in any weather conditions, to help predict landslides and floods, coordinate relief efforts in case of earthquakes or fires, [and] check crisis areas.” Primarily focused on the Mediterranean, the nature of sun-synchronous orbits (SSOs) nevertheless give SkyMed satellites views of most of the Earth’s surface every day.

SkyMed CSG-1 debuted on an Arianespace Soyuz rocket in December 2019, while CSG-2 was originally scheduled to launch sometime in 2021 on one of the first Arianespace Vega-C rockets. However, in July 2019 and November 2020, the Vega rocket Vega-C is based on suffered two launch failures separated by just a single success. Aside from raising major questions about operator Arianespace and Vega manufacturer Avio’s quality assurance, those near-back-to-back failures also delayed Vega’s launch manifest by years. Combined with limited launch cadence and a jam-packed manifest for Arianespace’s other rockets, that meant that Italy would have likely had to wait 1-2 years to launch SkyMed CSG-2 on a European or Italian-made rocket.

Apparently valuing a timely, affordable launch more than the path of least political resistance, the Italian Space Agency chose to remanifest the second SkyMed satellite on a SpaceX Falcon 9 rocket scheduled to launch no earlier than November 2021. However, based on ASI’s explanation of the move in the quote above, the space agency clearly felt a need to very carefully explain its decision while also repeatedly (and almost fearfully so) signaling its unwavering “trust” in and dedication to “key partner” Arianespace.

That part of the Italian Space Agency’s statement appeared to be a rather distinct reassertion of fealty to Arianespace is made even more unusual by the fact that the Vega rocket SkyMed CSG-2 was meant to fly on is mainly built in Italy by aerospace company Avio – independently owned but a major Arianespace supplier. Further, ASI directing the apologetic portion of its explanation to Arianespace is no less odd given that Arianespace is a private company theoretically independent of space agencies, while moving from Vega to Falcon 9 primarily impacts Avio more than Arianespace and risks raising the ire of Vega development partner ESA. Even further still, ASI itself – not ESA, Avio, or Arianespace – is the source of a majority of Vega development funding over the last decade and a half.

Regardless, at the simplest level, there are clear motivating factors for a space agency primarily funding the development of a certain launch vehicle to want to fly its own payloads on said self-funded rocket. However, after likely taking things a step further and encouraging ESA and the EU to commit to launching as many payloads as possible on its ESA-approved Vega rocket, the Italian Space Agency itself is now discovering the downsides of pushing for political arrangements beneficial to domestic industries while being forced to figure out just how politically viable it is to pursue non-European launch alternatives. There might be a small chance that Italy’s brief taste of freedom to use rockets other than Vega and Ariane 5/6 could encourage other EU members to push back and fight for access to cheaper, more reliable launches. However, it looks far more likely that SkyMed CSG-2 will be a rare outlier for years to come.

Advertisement

Eric Ralph is Teslarati's senior spaceflight reporter and has been covering the industry in some capacity for almost half a decade, largely spurred in 2016 by a trip to Mexico to watch Elon Musk reveal SpaceX's plans for Mars in person. Aside from spreading interest and excitement about spaceflight far and wide, his primary goal is to cover humanity's ongoing efforts to expand beyond Earth to the Moon, Mars, and elsewhere.

Advertisement
Comments

Elon Musk

Tesla CEO Elon Musk hits back at drug use claims, calls publications ‘hypocrites’

Elon Musk showed a clean drug test, dispelling any rumors of drug use that came from unfounded reports from two large media outlets.

Published

on

Credit: Elon Musk

Tesla CEO Elon Musk has responded to a report from the Wall Street Journal and the New York Times, as both publications claimed he was abusing drugs while being involved with President Trump on both the campaign trail and while he was active within the administration after the election.

A bombshell report from the New York Times, published in late May, stated that Musk was regularly using things like ketamine, ecstasy, and psychedelic mushrooms, and also stimulants like Adderall, during his time within the Trump administration.

The reports cited inside sources who claimed the Tesla and SpaceX frontman was using substances during his time with the government.

However, Musk published the results of a recent drug test performed at Fastest Labs of South Austin. They showed ‘Negative’ results across the board:

Musk was not done there.

He went on to say the New York Times “lies as easy as breathing. It’s normal for them.” He also said both the Times and Wall Street Journal reporters should also publish their own drug test results, stating, “They won’t, because those hypocrites are guilty as sin.”

Musk said years ago that he received ketamine prescriptions from doctors to treat depression. He said he had it “years ago and said so on X, so this is not even news.” He also said that ketamine “helps for getting out of dark mental holes, but haven’t taken it since then.”

Tesla fans and Musk enthusiasts have joked for days now that, if Musk were to be on drugs, other CEOs should also do them, considering his persistence on work-related projects, long hours, and commitment to his job.

Musk has now proven that there has been no drug use with this test, and it seems as if the reports could have some sort of legal impact, although he has not said he will take any action.

Continue Reading

News

Tesla’s Grok integration will be more realistic with this cool feature

Tesla is preparing Grok for its first integration into vehicles, but it’s making it more robust than ever, firmware shows.

Published

on

Credit: Tesla

Tesla has not yet integrated the AI assistant Grok into its vehicles, but when it does, it will be even more realistic with a new feature that firmware coding shows.

CEO Elon Musk teased a few months back that Grok would be making its way into vehicles in the near future. The implementation has not yet occurred, but we are confident it will be rolling out soon, especially as Tesla has its sights set on a near-term rollout of the Robotaxi platform.

Tesla’s vehicles expected to get Grok voice assistant—but when?

Grok will enable AI assistance for drivers who are both manually operating Tesla vehicles or using the company’s Full Self-Driving suite. It has been widely popular and extremely useful for users on X, Musk’s social media platform.

However, Tesla hacker green has revealed through firmware that the company is planning to roll out Grok into vehicles with personalities, giving it an even more realistic tone that is totally customizable and catered to whatever the driver wants.

There are also a handful of kids’ versions that will do things like tell stories or play trivia:

The true capabilities of Grok are nearly limitless. Back in January, Musk said on a livestream on X that, “You’ll be able to talk to your Tesla and ask for anything.”

Grok appears to only be available on AMD-based vehicles, according to other things green found in the firmware. This means that Intel-based Teslas, which are usually older models, will not enable Grok support for right now.

Continue Reading

News

Tesla dominates Cars.com’s Made in America Index with clean sweep

Tesla continues to dominate Cars.com’s Made in America Index with a clean sweep of the Top 4 spots.

Published

on

Credit: Tesla

Tesla has dominated the Cars.com Made-in-America Index with a clean sweep of the top four spots. All four Tesla vehicles that were eligible for the analysis placed in the top four.

The Model 3 overtook the Model Y for first place this year. The all-electric crossover was first in 2024, but the Model 3 managed to overtake its sibling vehicle to claim the top spot in 2025. The Model Y took second, while the Model S took third, and the Model X took fourth.

This is an improvement from last year, as the Model Y took first, but the Model S and Model X placed fourth and ninth, respectively. The Model 3 was not in the Top 10 in 2024.

“Tesla continues to lead, claiming the top four spots and showcasing its commitment to domestic production. About 25% of the more than 400 vehicles on sale in the U.S. made this year’s AMI, and whether a vehicle is No. 1 or No.99, it contributes to the U.S. economy,” Patrick Masterson, lead researcher for the program, said.

More than 400 vehicles were analyzed for this year’s study, with Cars.com officially ranking 117 of them. There were two other EVs in the Top 10, as the Kia EV6 took sixth place, and the Volkswagen ID.4 finished in tenth.

This year’s study reflected major geographic and strategic shifts across the automotive industry. Of the 117 vehicles ranked in the program, they were produced at 36 domestic factories, leaving only 11 total factories that did not yield a car on the list. There are 47 assembly plants in operation in the U.S.

However, there still has not been a vehicle to quite reach the 100 percent domestic parts content, something that is extremely elusive. Masterson says the global supply chain is still extremely crucial to even the most American-built cars on the market.

The average domestic parts content of the Top 10 cars was 83.4 percent in 2006, but that number has shrunk to 70.3 percent in this year’s rankings.

Some might wonder where cars like the Tesla Cybertruck or Rivian R1T are on the list. However, these vehicles did not qualify because the study only considers cars under a gross weight of 8,500 pounds.

Continue Reading

Trending